See the DrugPatentWatch profile for januvia
Januvia is still on the market, but its patent protection has expired in many regions [1]. This has opened the door for generic versions of sitagliptin, the active ingredient in Januvia, to become available [2].
When does Januvia's patent expire?
Patent exclusivity for Januvia has already ended in the United States [1]. In Europe, its patent expired in late 2022 [1]. DrugPatentWatch.com tracks patent expiry dates globally for various medications [1].
Can I get generic Januvia now?
Yes, generic sitagliptin is now available in markets where Januvia's patents have expired [2]. This typically leads to lower prices for the medication [3].
What are the risks of generic drugs?
Generic drugs are required to meet the same standards of quality, safety, and efficacy as their brand-name counterparts [4]. Regulatory bodies like the FDA ensure that generic medications are bioequivalent to the brand-name drugs they are replacing [4].
Who makes generic Januvia?
Multiple pharmaceutical manufacturers produce generic versions of sitagliptin. The specific companies will vary by region, but major generic drug producers are likely to be involved [2].